share_log

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%), etc.

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%), etc.

Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%)等
美股sec公告 ·  03/19 22:29
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息